Unexplained infertility occurs when standard evaluations show no clear reason for difficulties in conceiving. Many patients receive this diagnosis after normal findings in hormone assessment, semen analysis, and imaging. For patients undergoing in vitro fertilization (IVF), this diagnosis shifts the focus to a deeper investigation of factors influencing implantation. Here is more information to help you navigate a diagnosis of unexplained infertility:
Understand the Diagnosis
Clinicians assign an unexplained infertility diagnosis when typical reproductive assessments appear normal, and no structural or hormonal irregularities are detected. Because the evaluation focuses on standard measurable factors, this diagnosis leaves open the possibility of other influences on conception and implantation. The diagnosis criteria for silent infertility typically involve having at least one open fallopian tube, a regular menstrual cycle, and a normal semen analysis. It may also refer to not conceiving after a certain period of trying; the length of that time varies depending on factors such as age.
The evaluation typically begins with confirming ovulation. Progesterone testing can be used to assess whether ovulation is occurring, and semen analysis looks at factors such as sperm morphology, motility, and count. Ovarian reserve may be assessed by measuring hormones like Follicle Stimulating Hormone (FSH) and Anti-Müllerian Hormone (AMH). Clinicians are also able to perform a laparoscopy to visualize the pelvic reproductive organs, particularly when endometriosis is a concern.
Learn About Factors Affecting Implantation
Differences in the uterus affect how an embryo interacts with the uterine lining. Immune activity, hormonal signaling, and tissue response all play roles in this process, as they shape the conditions for implantation. When these processes are disrupted, implantation may be less likely, and routine fertility tests do not always capture these factors. Subtle variations in gland distribution, tissue thickness, and blood flow also influence how the uterus supports implantation by affecting its structure and function.
Conditions such as silent endometriosis may be associated with inflammation and can occur without clear symptoms; this detection more challenging. Some approaches look at molecular markers in the endometrium to better understand the uterine environment. Testing may examine levels of BCL6, a protein linked to inflammatory pathways, which is associated with changes in uterine receptivity.
For patients thinking about trying IVF, uterine factors are one part of the overall picture. Certain tests focus on how the endometrium and embryo interact, which highlights factors not addressed in standard evaluations. Implantation depends on both embryo viability and endometrial conditions; embryo-focused assessments alone do not reflect uterine influences. In some cases, care plans include steps aimed at supporting the uterine environment before embryo transfer.
Explore Diagnostic Testing Options
Tests that look at biomarkers linked to inflammation in the endometrium are sometimes included in further evaluation. A clinician may recommend assessing BCL6 expression using a small tissue sample. The sample is often collected in the mid-luteal phase, a point in the cycle associated with the implantation window; this approach highlights patterns that are not visible on imaging. Higher BCL6 expression has been associated with endometriosis, including in people without clear symptoms such as pelvic pain. When inflammatory markers are present, clinicians explore additional evaluations for underlying conditions, and the findings help inform next steps. This type of assessment may be tried by patients undergoing IVF who want more information before starting or repeating a cycle.
Evaluate Treatment Options
Clinicians use these findings to guide whether to proceed with embryo transfer or try further evaluation first. Delaying the transfer allows time to address factors linked to inflammation. Adjustments involve medication, timing, or management of underlying conditions before proceeding.
Some patients also try less invasive options such as intrauterine insemination (IUI), while others pursue IVF. Factors like age, prior treatment history, and how long someone has been trying to conceive often influence these choices. Decisions are typically based on individual findings rather than a single standard approach. Aligning evaluation and treatment helps guide next steps in cases of unexplained infertility.
Explore Solutions for Unexplained Infertility
Diagnostic clarity shapes how clinicians structure each treatment cycle. Selecting uterine-focused testing adds specific information to a process that often relies on general clinical signs. It brings more factors into cycle planning, not just those related to embryo selection. Contact specialists for an unexplained infertility consultation.
